Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LPAR6 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | NPEPL1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | INTS9 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
mRNA | DACT1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | KLHL12 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | CFAP157 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | HIST2H3D | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | DEAF1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | TRADD | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | SHTN1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |